KJ77
11-02-2008, 12:01 AM
(Porter Novelli) Shire plc, the global specialty biopharmaceutical company, announced results from a 13-hour classroom study in children aged 6 to 12 years with attention deficit hyperactivity disorder, in which researchers found that VYVANSE CII controlled ADHD symptoms from the first time measured (1.5 hours) through the last time point assessed (13 hours) post-dose. The study findings were at a national psychiatric meeting in Chicago. (Source: EurekAlert! - Medicine and Health)
More... (http://www.eurekalert.org/pub_releases/2008-10/pn-vpb102908.php)
More... (http://www.eurekalert.org/pub_releases/2008-10/pn-vpb102908.php)